Stock Information
Vertex Pharmaceuticals Incorporated (VRTX)
Ticker Symbol: VRTX
Exchange: NASDAQ
Sector: Biotechnology
Market Cap: $136,514.05 mil
Piotroski score: 3
PE Ratio: 32.64
EPS (TTM): 15.54
Revenue (TTM): $50.75 M
Dividend Yield: N/A
ROE: 20.08%
Latest News
-
Is It Too Early To Buy Insmed Stock?
Fri, Nov 20, 2026 2:29 PM
-
Has Vertex Stock Become A Different Bet?
Fri, Nov 20, 2026 12:28 PM
-
Jim Cramer Rejects UiPath Despite Cheap Valuation, Backs Affirm
Fri, Nov 20, 2026 8:52 AM
-
Vertex Pharmaceuticals: Look For Povetacicept Approval In 2 Weeks As Next Catalyst
Fri, Nov 20, 2026 7:21 AM
-
2 Growth Stocks to Buy in November Without Any Hesitation
Thu, Nov 19, 2026 6:03 PM
-
Genomics, Vertex extend drug discovery alliance in $220m deal
Thu, Nov 19, 2026 10:53 AM
-
Should You Pick Vertex Stock Over Its Biotech Rivals?
Wed, Nov 18, 2026 5:13 PM
-
Rhythm Pharma: Is AstraZeneca/Eli Lilly's Bidding War For Real? Don't Rule It Out
Wed, Nov 18, 2026 2:16 PM
-
The Women’s Edge and The Boston Globe Again Name CCC to Top 100 Women-Led Businesses in Massachusetts List
Wed, Nov 18, 2026 1:30 PM
-
iShares Biotechnology ETF (IBB) Buys $16.2 Million More Gilead on Nov. 16
Wed, Nov 18, 2026 11:05 AM
Key Financials
Financial data not available